Company: INMB
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003354
Chunk: 228

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 228
---
    Cash and cash equivalents 
    $20,922  
    $35,848 
  
    Research and development tax credit receivable 
     1,181  
     1,905 
  
    Other tax receivable 
     228  
     537 
  
    Prepaid expenses and other current assets 
     331  
     1,510 
  
    Prepaid expenses – related party 
     -  
     142 
  
    TOTAL CURRENT ASSETS 
     22,662  
     39,942 

    Operating lease – right of use asset 
     307  
     414 
  
    Other assets 
     79  
     131 
  
    Acquired in-process research and development intangible assets 
     16,514  
     16,514 

    TOTAL ASSETS 
    $39,562  
    $57,001 

    LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ EQUITY 

    CURRENT LIABILITIES 

    Accounts payable and accrued liabilities 
    $6,539  
    $7,901 
  
    Accounts payable and accrued liabilities – related parties 
     25  
     35 
  
    Deferred liabilities 
     517  
     489 
  
    Current portion of long-term debt, net 
     -  
     9,921 
  
    Operating lease, current liability 
     140  
     119 
  
    TOTAL CURRENT LIABILITIES 
     7,221  
     18,465 

    Long-term operating lease liability 
     244  
     397 
  
    TOTAL LIABILITIES 
     7,465  
     18,862 

    COMMITMENTS AND CONTINGENCIES 

    Redeemable common stock, $0.001 par value; 0 and 75,697 shares issued and outstanding, respectively (Note 9) 
     -  
     799 

    STOCKHOLDERS’ EQUITY 

    Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding 
     -  
     - 
  
    Common stock, $0.001 par value, 200,000,000 shares authorized, 22,280,451 and 17,950,